An isolated viral load test may generate false positive results for people using long-acting PrEP
July 23, 2024
July 23, 2024
WASHINGTON, July 23 -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
Analysis from large NIH study offers new insight on clinical utility of current U.S. testing algorithm.
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect HIV in a multi-country study. In . . .
Analysis from large NIH study offers new insight on clinical utility of current U.S. testing algorithm.
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect HIV in a multi-country study. In . . .